Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mycoses × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 138 Breast Neoplasms 91 Colorectal Neoplasms 67 Neoplasms 56 Lung Neoplasms 50 Stomach Neoplasms 47 Neoplasm Metastasis 45 Pancreatic Neoplasms 43 Rectal Neoplasms 39 Ovarian Neoplasms 39 Esophageal Squamous Cell Carcinoma 36 Esophageal Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 28 Head and Neck Neoplasms 28 Leukemia, Myeloid, Acute 26 Triple Negative Breast Neoplasms 21 Recurrence 21 Small Cell Lung Carcinoma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Nasopharyngeal Carcinoma 20 Colonic Neoplasms 20 Lymphoma 17 Glioblastoma 17 Fallopian Tube Neoplasms 17 Uterine Cervical Neoplasms 16 Prostatic Neoplasms 16 Lymphoma, Non-Hodgkin 16 Sarcoma 15 Leukemia 14 Carcinoma, Squamous Cell 14

Interventions

Voriconazole 4 posaconazole 3 Fluconazole 3 Standard of Care 2 Itraconazole 2 Caspofungin 2 liposomal amphotericin B 1 Therapeutics 1 Lymphatic Irradiation 1 Levofloxacin 1 Drug Therapy 1 Cyclosporine 1 Antilymphocyte Serum 1 Amphotericin B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03301597 2021-03-30

LAUNCH

Nohla Therapeutics, Inc.

Phase 2 Terminated

Other hematologic neoplasm

Bacterial Infections, Mycoses, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡